References
- Sergeant N, Bretteville A, Hamdane M et al. Biochemistry of tau in Alzheimer’s disease and related neurological disorders. Expert Rev. Proteomics 5(2), 207–224 (2008).
- Burnouf S, Martire A, Derisbourg M et al. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a tau transgenic model. Aging Cell 12(1), 11–23 (2013).
- Blum D, Sandau U, Laurent C et al. Adenosine receptors in Alzheimer’s disease. In: Adenosine: a key link between metabolism and CNS activity. Masino S, Boison D (Eds) Springer, Berlin, Germany (2012).
- Belarbi K, Burnouf S, Fernandez-Gomez FJ et al. Beneficial effects of exercise in a transgenic mouse model of Alzheimer’s disease-like tau pathology. Neurobiol. Dis. 43(2), 486–494 (2011).
- Le Freche H, Brouillette J, Fernandez-Gomez FJ et al. Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology 116(4), 779–787 (2012).
- Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 7(3), 137–152 (2011).
- Mrak RE. Alzheimer-type neuropathological changes in morbidly obese elderly individuals. Clin. Neuropathol. 28(1), 40–45 (2009).
- Maesako M, Uemura K, Kubota M et al. Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J. Biol. Chem. 287(27), 23024–23033 (2012).
- Jeon BT, Jeong EA, Shin HJ et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 61(6), 1444–1454 (2012).
- Moroz N, Tong M, Longato L, Xu H, de la Monte SM. Limited Alzheimer-type neurodegeneration in experimental obesity and Type 2 diabetes mellitus. J. Alzheimers Dis. 15(1), 29–44 (2008).
- Becker K, Freude S, Zemva J, Stöhr O, Krone W, Schubert M. Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in vivo. Neurosci. Lett. 516(2), 306–310 (2012).
- Leboucher A, Laurent C, Fernandez-Gomez FJ et al. Detrimental effects of diet-induced obesity on t pathology is independent of insulin resistance in t transgenic mice. Diabetes doi:10.2337/db12-0866 (2012) (Epub ahead of print).
- Pistell PJ, Morrison CD, Gupta S et al. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J. Neuroimmunol. 219(1–2), 25–32 (2010).
- Papon MA, El Khoury NB, Marcouiller F et al. Deregulation of protein phosphatase 2A and hyperphosphorylation of t protein following onset of diabetes in NOD mice. Diabetes 62(2), 609–617 (2013).
- Planel E, Tatebayashi Y, Miyasaka T et al. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J. Neurosci. 27(50), 13635–13648 (2007).
- Ke YD, Delerue F, Gladbach A, Götz J, Ittner LM. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer’s disease. PLoS ONE 4(11), e7917 (2009).
- Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong CX. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer’s disease. Am. J. Pathol. 175(5), 2089–2098 (2009).
- Schubert M, Gautam D, Surjo D et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl Acad. Sci. USA 101(9), 3100–3105 (2004).
- Talbot K, Wang HY, Kazi H et al. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122(4), 1316–1338 (2012).
- Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer’s disease and diabetes. J. Pathol. 225(1), 54–62 (2011).
- Matsuzaki T, Sasaki K, Tanizaki Y et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 75(9), 764–770 (2010).
Website
- Genes uncovered in Alzheimer’s disease genome-wide association studies. www.alzgene.org